Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE006845 |
YEM_ID: | YEM-710 |
YNS_ID: | YNS-144 |
ID: | TCMBANKHE006845/YNS-144/YEM-710 |
植物拉丁名: |
|
功能与主治: | 祛痰催吐，解毒消肿，活血散结，杀虫。用于食物中毒，咽喉肿痛，痰涎壅塞，痰核，瘰疬，痈疽肿毒。|To dispel phlegm and promote vomiting, resolve toxin and dissipate binds./Poliomyelitis, muscle weakness, rheumatic arthritis, pain in joints due to rheumatalgia, throat wind, nipple moth, swelling pain in throat, phlegm-drool and congesting lung, food poisoning, seeper in chest and abdomen, malign sore and swelling toxin, hemorrhoids and fistulas, knocks and falls, intractable lichen, burns and scalds, snake bite. |
药用植物名: | 石蒜 |
药名: | 老鸦蒜|石蒜 |
来源: | 云南药材标准：第六册|云南民族药物志：第四卷 |
药用部位: | bulb|干燥鳞茎 |
使用民族: | 水族/彝族 |
科: | 石蒜科 |
属: | 石蒜属 |
TCM_ID_id: | 1155 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000038 | prim-o-glucosylcimifugin | NP-002658; ACon1_000472; BRD-A58428623-001-01-6; MCULE-1156118860; MEGxp0_000922; MolPort-001-741-075; NCGC00169046-01 | C22H28O11 | 468.4 g/mol | CC(C)(C1CC2=C(O1)C=C3C(=C2OC)C(=O)C=C(O3)COC4C(C(C(C(O4)CO)O)O)O)O |
| TCMBANKIN000168 | (+)-galbacin | C20H20O5 | 340.4 g/mol | CC1C(C(OC1C2=CC3=C(C=C2)OCO3)C4=CC5=C(C=C4)OCO5)C | |
| TCMBANKIN005404 | Hippeastrine | BPBio1_000847; STOCK1N-52692; BSPBio_000769; NSC731436; Lycorenan-7-one, 5-hydroxy-1-methyl-9,10-(methylenebis(oxy))-, (5alpha)-; 30803-79-3; hippeastrine; C08528; 477-17-8; Prestwick3_000675 | C17H17NO5 | 315.32 | CN1CCC2=CC(C3C(C21)C4=CC5=C(C=C4C(=O)O3)OCO5)O |
| TCMBANKIN006802 | homolycorine | C18H21NO4 | 315.4 g/mol | CN1CCC2=CCC3C(C21)C4=CC(=C(C=C4C(=O)O3)OC)OC | |
| TCMBANKIN007636 | n-demethylnicaustrine | C42H52N2O11 | CC1=C2C(C(C3(CCC(C4(C3C(C(C2(C)C)CC1OC(=O)C)OC(=O)C)CO4)OC(=O)CC(C5=CC=CC=C5)NC)C)OC(=O)C6=CN=CC=C6)OC(=O)C | ||
| TCMBANKIN008568 | tadehaginoside | C21H22O10 | C1=CC(=CC=C1C=CC(=O)OCC2C(C(C(C(O2)OC3=CC(=CC(=C3)O)O)O)O)O)O | ||
| TCMBANKIN009232 | 7,3'-dihydroxy-4'-methoxy-8-methylflavan | LMPK12020239; AK556082; CHEBI:2244; DTXSID60331807; SCHEMBL17559175; CTK3E9492; 87733-81-1; (2S)-2-(3-hydroxy-4-methoxyphenyl)-8-methyl-3,4-dihydro-2H-1-benzopyran-7-ol; AKOS030531386; (S)-2-(3-Hydroxy-4-methoxyphenyl)-8-methylchroman-7-ol; C09646; (2S)-2-(3-hydroxy-4-methoxy-phenyl)-8-methyl-chroman-7-ol; (2S)-2-(3-hydroxy-4-methoxyphenyl)-8-methyl-3,4-dihydro-2H-chromen-7-ol; AC1L9CO5; 7,3'-Dihydroxy-4'-methoxy-8-methylflavan | C17H18O4 | 286.32 g/mol | CC1=C(C=CC2=C1OC(CC2)C3=CC(=C(C=C3)OC)O)O |
| TCMBANKIN009560 | lycoramine | C17H23NO3 | 289.37 | CN1CCC23CCC(CC2OC4=C(C=CC(=C34)C1)OC)O.Br | |
| TCMBANKIN009662 | hippuric acid | hippuricacid | C9H9NO3 | 179.17 g/mol | C1=CC=C(C=C1)C(=O)NCC(=O)O |
| TCMBANKIN010568 | lycoxanthin | C40H56O | 552.9 g/mol | CC(=CCCC(=CC=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC=C(C)CCC=C(C)CO)C)C)C)C | |
| TCMBANKIN011752 | 2-epi-jatrogrossidion | ||||
| TCMBANKIN012106 | n-methyldendrobium | C17H28NO2+ | CC(C)C1C2C3CCC4C3(C(C1OC2=O)[N+](C4)(C)C)C | ||
| TCMBANKIN013638 | lycorenine | C18H23NO4 | 317.4 g/mol | CN1CCC2=CCC3C(C21)C4=CC(=C(C=C4C(O3)O)OC)OC | |
| TCMBANKIN017367 | galanthamine | Jilkon hydrobromide; SC-17309; 1,2,3,4,6,7,7a,11c- Octahydro-9- methoxy-2-methyl-benzofuro (4,3,2-efg)(2) benzazocin-6-ol hydrobromide; 1,2,3,4,6,7,7a,11c-Octahydro-9-methoxy-2-methyl-benzofuro (4,3,2-efg)(2) benzazocin-6-ol hydrobromide; SR-01000315928-1; Q-201145; Lycoremine hydrobromide; MolPort-035-394-945; SR-01000315928 | C17H21NO3 | 287.35 g/mol | CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O |
| TCMBANKIN017816 | tazettine | C18H21NO5 | 331.4 g/mol | CN1CC2(C3(C1CC(C=C3)OC)C4=CC5=C(C=C4CO2)OCO5)O | |
| TCMBANKIN019490 | norpluviine | C16H19NO3 | 273.33 g/mol | COC1=C(C=C2CN3CCC4=CCC(C(C43)C2=C1)O)O | |
| TCMBANKIN020919 | lycoricidine | C14H13NO6 | 291.26 g/mol | C1OC2=C(O1)C=C3C(=C2)C4=CC(C(C(C4NC3=O)O)O)O | |
| TCMBANKIN023727 | pseudolycorine | C7H6O3 | 138.12 | COC1=C(C=C2C3C(C(C=C4C3N(CC4)CC2=C1)O)O)O | |
| TCMBANKIN024019 | 3,3'-diiodothyronine | C15H13I2NO4 | 525.08 g/mol | C1=CC(=C(C=C1CC(C(=O)O)N)I)OC2=CC(=C(C=C2)O)I | |
| TCMBANKIN025350 | pluviine | C17H21NO3 | 287.35 g/mol | COC1=C(C=C2C3C(CC=C4C3N(CC4)CC2=C1)O)OC | |
| TCMBANKIN025770 | homomangiferin | C20H20O11 | 436.4 g/mol | COC1=C(C(=C2C(=C1)OC3=CC(=C(C=C3C2=O)O)O)O)C4C(C(C(C(O4)CO)O)O)O | |
| TCMBANKIN026380 | pseudomorphine | C34H36N2O6 | 568.7 g/mol | CN1CCC23C4C1CC5=CC(=C(C(=C52)OC3C(C=C4)O)O)C6=C(C7=C8C(=C6)CC9C1C8(CCN9C)C(O7)C(C=C1)O)O | |
| TCMBANKIN029658 | o-methyldeoxopunjabine | C36H36N2O6 | 592.7 g/mol | CN1CCC2=CC3=C(C=C2C1)OC4=C5C(N(CCC5=CC(=C4O3)OC)C)CC6=CC=C(C=C6)OC7=C(C=CC(=C7)C=O)OC | |
| TCMBANKIN033851 | pretazettine | C18H21NO5 | 331.4 g/mol | CN1CC2C3(C1CC(C=C3)OC)C4=CC5=C(C=C4C(O2)O)OCO5 | |
| TCMBANKIN034885 | 9-demethylhomolycorine | C17H19NO4 | CN1CCC2=CCC3C(C21)C4=CC(=C(C=C4C(=O)O3)O)OC | ||
| TCMBANKIN038355 | voacamine | voacamine | C43H52N4O5 | 704.9 g/mol | CCC1CC2CC3(C1N(C2)CCC4=C3NC5=CC(=C(C=C45)OC)C6CC7C(C(CC8=C6NC9=CC=CC=C89)N(CC7=CC)C)C(=O)OC)C(=O)OC |
| TCMBANKIN038668 | (+)-Crinine | 271.31 g/mol | |||
| TCMBANKIN043407 | lycoricyanin | C26H29O15+ | |||
| TCMBANKIN043842 | Ungeremine | 266.27 g/mol | |||
| TCMBANKIN048684 | Podecdysone B | 462.6 g/mol | |||
| TCMBANKIN058518 | epigallocatechin | Spectrum5_000889; (2S,3R)-2-(3,4,5-Trihydroxyphenyl)-chroman-3,5,7-triol; 08108_FLUKA; KBio2_003854; KBioSS_001286; epi-Gallocatechin; (−)-Epigallocatechin; SPBio_000885; Epigallocatechol; (2S,3S)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; AIDS-001348; Spectrum_000806; NCI60_026204; BCBcMAP01_000207; (2S,3S)-(+)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; MCULE-9338438267; CCRIS 5441; CHEBI:42255; Spectrum4_000950; 136892-45-0; (2R,3R)-2-(3,4,5-trihydroxyphenyl)chroman-3,5,7-triol; (3,3',4',5,5',7-Hexahydroxyflavan); (−)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol; SCHEMBL1972938; (+)-epigallocatechin; AIDS001348; KBio3_001136; SDCCGMLS-0066479.P001; EGC; 1-epi-3',4',5,5',7-Pentahydroxy-3-Flavan; NSC674039; 2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, (2R-cis)- (9CI); 970-74-1; E3768_SIAL; EPIGALLOCATECHIN; C12136; 2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, (2R-cis)-; KBio2_006422; Antiscurvy factor C2; NCGC00180795-01; SpecPlus_000269; Factor C2 (antiscurvy); (-)cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol; (-)-3,3',4',5,5',7-Flavanhexol; 98032-84-9; l-Epigallocatechol; MolPort-001-740-311; 3,3',4',5,5',7-Flavanhexol; BSPBio_001636; (-)-Epigallocatechol; (2S,3S)-2-(3,4,5-Trihydroxy-phenyl)-chroman-3,5,7-triol; (-)-Epigallocatechin; (2R,3R)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; 3BC1BF1C-D95B-4EB2-943E-C1F59C7501A0; KBio1_001309; (2S,3S)-epigallocatechin; KBioGR_001540; SPECTRUM205113; ZINC3870339; CHEBI:71227; (2S,3S)-flavan-3,3',4',5,5',7-hexol; CHEMBL130415; (+)-epi-gallocatechin; NP-000358; Spectrum3_000248; (−)-cis-3,3′,4′,5,5′,7-Hexahydroxyflavane; 2-(3,4,5-TRIHYDROXY-PHENYL)-CHROMAN-3,5,7-TRIOL; (+)-cis-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol; Antiscurvy factor C(sub 2); 2545-09-7; ACon1_000192; SMP1_000114; KBio2_001286; L-Epigallocatechin; DivK1c_006365; (2S,3S)-2-(3,4,5-TRIHYDROXYPHENYL)-3,4-DIHYDRO-2H-1-BENZOPYRAN-3,5,7-TRIOL; Spectrum2_000703; (+)-cis-3,3',4',5,5',7-hexahydroxyflavane; BDBM50135171; (2S,3S)-flavan-3,5,7,3',4',5'-hexol;l-epigallocatechin | C15H14O7 | 306.27 | C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)O |
| TCMBANKIN058634 | lycorine | AC-20268; CHEMBL583716; 2-epi-Lycorine; ZINC21992900; AKOS015965245; Licorine; NCI60_003767; UNII-I9Q105R5BU; ST24047513; Amarylline; HMS3402B04; QTL1_000052; AN-24834; HMS1989B04; 3,3a-Didehydrolycoran-1alpha,2beta-diol; NSC-683873; AN-50515; AJ-46629; AX8136904; KBio3_000043; 3,12-[methylenebis(oxy)]-galanthan-1.alpha.,2.beta.-diol; MolPort-000-882-129; Galanthidine; Bio2_000022; KBioSS_000022; Lycorine hydrochloride; DTXSID60197208; NCGC00163413-02; EINECS 207-503-6; KBio2_005158; ZINC3881372; KBio2_000022; AC1L2HYJ; 2,4,5,7,12b,12c-Hexahydro-1H-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol, (1S,2S,12bS, 12cS)-; CHEBI:6601; SC-19266; CCG-208232; GNF-PF-4974; KBio3_000044; C08532; LS-88398; AC1Q6ZRB; Lycoran-1-alpha,2-beta-diol, 3,3-alpha-didehydro-; MFCD00243111; Lycoran-1alpha,2beta-diol, 3,3a-didehydro- (8CI); SCHEMBL626071; NSC683873; Bio2_000502; (-)-Lycorine; CHEMBL400092; IDI1_033772; KBioGR_000022; KBio2_002590; BDBM50221066; HMS1361B04; NSC-401360; Likorin; MFCD00221746; NSC 401360; NCGC00163413-01; I9Q105R5BU; BSPBio_001302; 9,10-(methylenedioxy)-3,12-didehydrogalanthan-1alpha,2beta-diol; lycorine; MCULE-4471227410; BRD-K64909280-001-02-7; Galanthan-1, 3,4-didehydro-11,12-[methylenebis(oxy)]-, (1.alpha.,2.beta.)-; Lycoran-1alpha,2beta-diol, 3,3a-didehydro-; 476-28-8; Galanthan-1, 3,12-didehydro-9,10-[methylenebis(oxy)]-, (1.alpha.,2.beta.)-; Lycoran-1.alpha., 3,3a-didehydro-; BCBcMAP01_000100; NSC401360; HMS1791B04; Galanthan-1,2-diol, 3,12-didehydro-9,10-(methylenebis(oxy))-, (1-alpha,2-beta)-; ST085774; STOCK1N-67168; SMP1_000184; Narcissine; Galanthan-1,2-diol, 3,12-didehydro-9,10-(methylenebis(oxy))-, (1-alpha,2-beta)- (9CI); AK115153; 3,2.beta.-diol; 2,5,7,12b,12c-Hexahydro-1H-[1,3]-dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol; AKOS000278045; (-)-lycorine; narcissine | C16H17NO4 | 287.31 g/mol | C1CN2CC3=CC4=C(C=C3C5C2C1=CC(C5O)O)OCO4 |
| TCMBANKIN058651 | lycoricidinol | narciclasine | C14H13NO7 | 307.25 g/mol | C1OC2=C(O1)C(=C3C(=C2)C4=CC(C(C(C4NC3=O)O)O)O)O |
| TCMBANKIN059104 | prim-o-glucosylcimifugin | NP-002658; ACon1_000472; BRD-A58428623-001-01-6; MCULE-1156118860; MEGxp0_000922; MolPort-001-741-075; NCGC00169046-01;prim-o-gluco sylcimifogin | C22H28O11 | 468.4 g/mol | CC(C)(C1CC2=C(O1)C=C3C(=C2OC)C(=O)C=C(O3)COC4C(C(C(C(O4)CO)O)O)O)O |
| TCMBANKIN060293 | (?)-zuonin a | C20H20O5 | 340.4 g/mol | CC1C(C(OC1C2=CC3=C(C=C2)OCO3)C4=CC5=C(C=C4)OCO5)C | |
| TCMBANKIN061922 | haemanthidine | 6-hydroxycrinamine | C17H19NO5 | 317.34 g/mol | COC1CC2C3(C=C1)C(CN2C(C4=CC5=C(C=C34)OCO5)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab